1-4 of 4
Ajay Kundra
Close
Sort by
Journal Articles

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms

Chi Chen, MD PhD, Anita Pandey, MBBS, MD, Ajay Kundra, MD, Sreenath Kodali, MBBS, MD, Ching Wong, MD, Tony W. Cheung, MD, Vladimir K. Gotlieb, MD, Gardith Joseph, MD, Sophia Tribie, Jen-Chin Wang, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4302.
https://doi.org/10.1182/blood-2018-99-112393
Published: 2018
Journal Articles

Comparison of Ruxolitinib , Momelotinib, and Pacritinib in the Inhibition of Immune Differentiation and Proliferation of T Cells in Myeloproliferative Neoplasm

Chi Chen, MD PhD, Hemant Sindhu, MD, Ajay Kundra, MD, Maryna Yarotska, MD, Tony W. Cheung, MD, Jen-Chin Wang, MD
Journal: Blood
Blood (2015) 126 (23): 5203.
https://doi.org/10.1182/blood.V126.23.5203.5203
Published: 2015
Journal Articles

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression and Myeloid Derived Suppressor Cells (MDSC) In Myeloid Neoplasms Implicate The Mechanism Of IMiD Treatment Of Myelofibrosis

Ajay Kundra, MD, Stacey Baptiste, MD, Chi Chen, MD, Ph, D, Hemant Sindhu, MD, Jen-Chin Wang, MD
Journal: Blood
Blood (2013) 122 (21): 2837.
https://doi.org/10.1182/blood.V122.21.2837.2837
Published: 2013
Journal Articles

Immune Derangements in Patients with Myelofibrosis- the Role of T reg, Th17, and sIL2α

Hemant Sindhu, MD, Ajay Kundra, Chi Chen, MD, Ph.D, Jen-Chin Wang, MD
Journal: Blood
Blood (2012) 120 (21): 1763.
https://doi.org/10.1182/blood.V120.21.1763.1763
Published: 2012